Regulation of transcriptional coactivator p300 by posttranslational modification
通过翻译后修饰调节转录辅激活因子 p300
基本信息
- 批准号:RGPIN-2017-03734
- 负责人:
- 金额:$ 2.91万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2018
- 资助国家:加拿大
- 起止时间:2018-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The transcriptional coactivator p300 possess an intrinsic histone acetyltransferase (HAT) activity and is important for many cellular processes. A tight control of p300 is therefore critical to ensure locus-specific histone acetylation and gene regulation. We have established previously that p300 is dynamically regulated by posttranslational modification and distinct cellular distribution. We are the first to show that p300 is modulated by the cytoplasmic proteasome system. In addition, we have established that Akt/protein kinase B is a positive regulator of p300, while the B56γ3 regulatory subunit of protein phosphatase 2A (PP2A) is a negative regulator. Our works have provided novel insights into how cellular trafficking and spatial redistribution control the protein stability and transcriptional activity of p300. Recently, we found that p300 is regulated in a lineage specific manner during myogenic differentiation. As such, we intend to leverage our findings to define the molecular mechanisms underlying lineage-specific p300 regulation associated with myoblast differentiation. ******We hypothesize that reversible phosphorylaton plays critical roles in the control of p300 activity, which in turn modulates p300 function during myoblast differentiation, and propose to define the functional interactions of the B56γ3 regulatory subunit, Akt, and additional kinases with p300, in milieu of myoblast differentiation. We will survey p300 phosphorylation profiles and delineate the regulation of p300 by reversible phosphorylation with gain- and loss-of-function approaches. We will generate mutants that mimic candidate site phosphorylation and produce antibodies against site-specific phosphorylation to study the impact of reversible phosphorylation on p300 stability and transcriptional activity. Our goals are to determine the molecular basis for posttranslational modification-mediated p300 regulation and their consequences on the function of p300 as a HAT, a scaffold or a bridge on chromatin with respect to gene transcription. We will define the molecular mechanisms underlying different signaling pathways and p300 regulation pertinent to cellular differentiation. Our long term goals are to determine how these regulatory mechanisms control p300-dependent gene expression from intracellular trafficking, protein turnover to transcriptional activation, and to determine the molecular basis for p300 function in a network biology fashion. ******This research program is founded upon our recent findings and anchored on the p300 which is essential for different cellular processes and skeletal myogenesis in vivo. Many HQP will be trained through the proposed research as shown by our proven track record, and as a result, they will be well equipped to navigate into their own career path successfully and to contribute to our research field and different Canadian organizations significantly.
转录辅激活因子p300具有内在的组蛋白乙酰转移酶(HAT)活性,并且对于许多细胞过程是重要的。 因此,对p300的严格控制对于确保基因座特异性组蛋白乙酰化和基因调控至关重要。 我们以前已经建立了p300是动态调节的翻译后修饰和不同的细胞分布。 我们是第一个表明,p300是由细胞质蛋白酶体系统调制。 此外,我们已经确定Akt/蛋白激酶B是p300的正调节因子,而蛋白磷酸酶2A(PP 2A)的B56γ3调节亚基是负调节因子。 我们的工作提供了新的见解,细胞运输和空间再分布控制蛋白质的稳定性和转录活性的p300。 最近,我们发现,p300的调控在一个谱系特异性的方式在肌分化。 因此,我们打算利用我们的研究结果来确定与成肌细胞分化相关的谱系特异性p300调控的分子机制。 ** 我们假设可逆磷酸化在控制p300活性中起关键作用,p300活性反过来调节成肌细胞分化过程中p300的功能,并提出在成肌细胞分化的环境中确定B56γ3调节亚基Akt和其他激酶与p300的功能相互作用。 我们将调查p300的磷酸化概况,并描绘了可逆的磷酸化与增益和功能丧失的方法调节p300。 我们将产生模拟候选位点磷酸化的突变体,并产生针对位点特异性磷酸化的抗体,以研究可逆磷酸化对p300稳定性和转录活性的影响。 我们的目标是确定翻译后修饰介导的p300调控的分子基础及其对p300作为HAT,支架或染色质上的桥梁基因转录功能的影响。 我们将定义不同的信号通路和p300调节相关的细胞分化的分子机制。 我们的长期目标是确定这些调控机制如何控制p300依赖的基因表达,从细胞内运输,蛋白质周转到转录激活,并确定p300功能的分子基础,在网络生物学的时尚。** 这项研究计划是建立在我们最近的发现和锚定的p300是必不可少的不同的细胞过程和骨骼肌在体内的发生。 许多HQP将通过拟议的研究进行培训,正如我们已证明的记录所示,因此,他们将能够成功地进入自己的职业道路,并为我们的研究领域和不同的加拿大组织做出重大贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Li, Qiao其他文献
Adverse Event Profile for Nanoparticle Albumin-Bound Paclitaxel Compared With Solvent-Based Taxanes in Solid-Organ Tumors: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- DOI:
10.1177/10600280211058385 - 发表时间:
2022-08 - 期刊:
- 影响因子:2.9
- 作者:
He, Fei;Liu, Jiaxuan;Shen, Xin;Wang, Zijing;Li, Qiao;Li, Guohui - 通讯作者:
Li, Guohui
Identifying the effects of industrial land expansion on PM2.5 concentrations: A spatiotemporal analysis in China
- DOI:
10.1016/j.ecolind.2022.109069 - 发表时间:
2022-06-15 - 期刊:
- 影响因子:6.9
- 作者:
Li, Qiao;Chen, Wei;Wang, Yanan - 通讯作者:
Wang, Yanan
Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer: a retrospective multicenter study.
- DOI:
10.1177/17588359231204856 - 发表时间:
2023 - 期刊:
- 影响因子:4.9
- 作者:
Jiang, Mingxia;Shao, Bin;Wan, Donggui;Liu, Jiaxuan;He, Maiyue;Chai, Yue;Sang, Die;Wang, Jiayu;Ma, Fei;Fan, Ying;Yuan, Peng;Xu, Binghe;Li, Qiao - 通讯作者:
Li, Qiao
The Integrity of α-β-α Sandwich Conformation Is Essential for a Novel Adjuvant TFPR1 to Maintain Its Adjuvanticity
- DOI:
10.3390/biom9120869 - 发表时间:
2019-12-01 - 期刊:
- 影响因子:5.5
- 作者:
Li, Qiao;Ning, Xiuzhe;Kou, Zhihua - 通讯作者:
Kou, Zhihua
Improving Worst-Case Latency Analysis for Rate-Constrained Traffic in the Time-Triggered Ethernet Network
改进时间触发以太网中速率受限流量的最坏情况延迟分析
- DOI:
10.1109/lcomm.2014.2358233 - 发表时间:
2014-09 - 期刊:
- 影响因子:0
- 作者:
Zhao, LuXi;Xiong, Huagang;Zheng, Zhong;Li, Qiao - 通讯作者:
Li, Qiao
Li, Qiao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Li, Qiao', 18)}}的其他基金
Regulation of transcriptional coactivator p300 by posttranslational modification
通过翻译后修饰调节转录辅激活因子 p300
- 批准号:
RGPIN-2017-03734 - 财政年份:2021
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Regulation of transcriptional coactivator p300 by posttranslational modification
通过翻译后修饰调节转录辅激活因子 p300
- 批准号:
RGPIN-2017-03734 - 财政年份:2020
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Regulation of transcriptional coactivator p300 by posttranslational modification
通过翻译后修饰调节转录辅激活因子 p300
- 批准号:
RGPIN-2017-03734 - 财政年份:2019
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Regulation of transcriptional coactivator p300 by posttranslational modification
通过翻译后修饰调节转录辅激活因子 p300
- 批准号:
RGPIN-2017-03734 - 财政年份:2017
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Effects of acetylation on the function of a transcriptional co-activator
乙酰化对转录共激活因子功能的影响
- 批准号:
250174-2012 - 财政年份:2015
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Effects of acetylation on the function of a transcriptional co-activator
乙酰化对转录共激活因子功能的影响
- 批准号:
250174-2012 - 财政年份:2014
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Effects of acetylation on the function of a transcriptional co-activator
乙酰化对转录共激活因子功能的影响
- 批准号:
250174-2012 - 财政年份:2013
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
Effects of acetylation on the function of a transcriptional co-activator
乙酰化对转录共激活因子功能的影响
- 批准号:
250174-2012 - 财政年份:2012
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
The role of the 26S proteasome in the regulation of mouse RAR beta gene expression
26S蛋白酶体在调控小鼠RARβ基因表达中的作用
- 批准号:
250174-2006 - 财政年份:2010
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
The role of the 26S proteasome in the regulation of mouse RAR beta gene expression
26S蛋白酶体在调控小鼠RARβ基因表达中的作用
- 批准号:
250174-2006 - 财政年份:2009
- 资助金额:
$ 2.91万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
- 批准号:82370751
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
辅酶A类代谢中间产物参与组蛋白表观遗传修饰调控肝细胞代谢网络对高油脂营养应答的机制研究
- 批准号:91957110
- 批准年份:2019
- 资助金额:83.0 万元
- 项目类别:重大研究计划
用dsDNA微阵列筛选NF-κB DNA靶点及靶基因
- 批准号:60871014
- 批准年份:2008
- 资助金额:35.0 万元
- 项目类别:面上项目
新的膀胱癌特异基因UCA1在膀胱癌高表达的分子机理
- 批准号:30801325
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
- 批准号:
10829620 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Developmental regulation of epithelial polarization by pre-mRNA splicing
mRNA前体剪接对上皮极化的发育调节
- 批准号:
10583675 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands
Nurr1与帕金森病危险因素的串扰及其配体的调控
- 批准号:
10677221 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Function and Regulation of MEIS1 in Vascular Disease
MEIS1在血管疾病中的功能和调控
- 批准号:
10723084 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Transcriptional Regulation of Dormancy and Emergence in Breast Cancer
乳腺癌休眠和出现的转录调控
- 批准号:
10658586 - 财政年份:2023
- 资助金额:
$ 2.91万 - 项目类别:
Regulation of the lens transcriptome and chromatin architecture by FOXE3
FOXE3 对晶状体转录组和染色质结构的调节
- 批准号:
10546497 - 财政年份:2022
- 资助金额:
$ 2.91万 - 项目类别:
The role of transcription factor Ying-Yang 1 in the cardiac bioenergetics regulation
转录因子Ying-Yang 1在心脏生物能调节中的作用
- 批准号:
10688160 - 财政年份:2022
- 资助金额:
$ 2.91万 - 项目类别:
Defining the regulation and regulatory mechanisms of TCF-1 in CD8+ T cell differentiation
明确TCF-1在CD8 T细胞分化中的调节和调控机制
- 批准号:
10605014 - 财政年份:2022
- 资助金额:
$ 2.91万 - 项目类别:
Crosstalk between Nurr1 and risk factors of Parkinson's disease and its regulation by Nurr1's ligands
Nurr1与帕金森病危险因素的串扰及其配体的调控
- 批准号:
10592731 - 财政年份:2022
- 资助金额:
$ 2.91万 - 项目类别:
Transcriptional regulation of mammary gland development
乳腺发育的转录调控
- 批准号:
10649420 - 财政年份:2022
- 资助金额:
$ 2.91万 - 项目类别: